Research Article
Mesenchymal Stem Cell Secretome Enhancement by Nicotinamide and Vasoactive Intestinal Peptide: A New Therapeutic Approach for Retinal Degenerative Diseases
Table 1
Pharmaceutical compositions.
| |||||||||||||||||||||||||||||||||||||||
aMSC: adipose-derived mesenchymal stem cells; CM: conditioned medium; NIC: nicotinamide; PhC: pharmaceutical compositions; VIP: vasoactive intestinal peptide. |